Surgical Management and Pathological Outcomes of Pet-Avid Solitary Pulmonary Nodules: A Single-Center Retrospective Cohort

Research Article

Authors

DOI:

https://doi.org/10.5281/zenodo.18900021

Keywords:

Solitary Pulmonary Nodule, FDG-PET/CT, SUVmax, Video-Assisted Thoracoscopic Surgery, Frozen Section

Abstract

Introduction: Fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) is frequently used to estimate malignancy risk in solitary pulmonary nodules (SPNs), yet false-positive uptake is common in inflammatory and granulomatous disease.

Objective: To describe our surgical management of PET-avid SPNs and to evaluate the association between maximum standardized uptake value (SUVmax) and malignancy.

Method: We retrospectively reviewed 69 consecutive patients with SPNs (≤3 cm) showing increased FDG uptake (SUVmax ≥2.5) who underwent surgery between December 2008 and September 2011 at Akdeniz University. All patients lacked a definitive diagnosis after noninvasive or minimally invasive attempts. The initial procedure was diagnostic wedge resection with intraoperative frozen section; surgery was terminated for benign lesions, whereas primary lung cancer prompted anatomic resection with systematic mediastinal lymph node sampling. Categorical variables were compared with chi-square and continuous variables with Student’s t-test or Mann–Whitney U test as appropriate (p<0.05).

Results: The cohort included 46 men (66.7%) and 23 women (33.3%), with a mean age of 58.16±12.11 years. Final pathology showed benign disease in 46.4%, primary lung cancer in 42.0%, and metastasis in 11.6%. Wedge resection was performed in 55.1% and anatomic resection in 44.9%. Mean SUVmax was significantly higher in malignant than benign nodules (10.54±7.30 vs 4.61±2.27; p<0.001).

Conclusion: Nearly half of PET-avid SPNs were benign, underscoring the limited specificity of FDG-PET/CT in endemic inflammatory settings. Higher SUVmax was associated with malignancy, but surgical resection remains a valuable diagnostic and potentially curative strategy when tissue diagnosis cannot be obtained otherwise.

References

Truong MT, Ko JP, Rossi SE, Rossi I, Viswanathan C, Bruzzi JF, Marom EM, Erasmus JJ. Update in the evaluation of the solitary pulmonary nodule. Radiographics. 2014;34(6):1658-79. doi: 10.1148/rg.346130092. PMID: 25310422.

Wyker A, Sharma S, Henderson WW. Solitary Pulmonary Nodule. 2024 Aug 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 32310603.

Hodnett PA, Ko JP. Evaluation and management of indeterminate pulmonary nodules. Radiol Clin North Am. 2012 Sep;50(5):895-914. doi: 10.1016/j.rcl.2012.06.005. PMID: 22974777.

Niyonkuru A, Chen X, Bakari KH, et al. FDG PET/CT in the evaluation of solitary pulmonary nodules. Cancer Med. 2020;9:3845–3854.

Deppen S, Putnam JB Jr, Andrade G, Speroff T, Nesbitt JC, Lambright ES, Massion PP, Walker R, Grogan EL. Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease. Ann Thorac Surg. 2011 Aug;92(2):428-32; discussion 433. doi: 10.1016/j.athoracsur.2011.02.052. Epub 2011 May 18. PMID: 21592456; PMCID: PMC3186439.

Jiménez MF; Spanish Video-Assisted Thoracic Surgery Study Group. Prospective study on video-assisted thoracoscopic surgery in the resection of pulmonary nodules: 209 cases from the Spanish Video-Assisted Thoracic Surgery Study Group. Eur J Cardiothorac Surg. 2001 May;19(5):562-5. doi: 10.1016/s1010-7940(01)00650-9. PMID: 11343931.

Bryant AS, Cerfolio RJ. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules. Ann Thorac Surg. 2006 Sep;82(3):1016-20. doi: 10.1016/j.athoracsur.2006.03.095. PMID: 16928527.

Erasmus JJ, Connolly JE,McAdams HP, Roggli VL. Solitary pulmonarynodules: Part I. Morphologic evaluation for differentiation of benign andmalignantlesions. Radiographics.2000;20(1):43-58.

Swensen SJ,Jett JR, Sloan JA, Midthun DE, Hartman TE,Sykes AM, et al.Screening for lung cancer with low-dose spiral computed tomography.Am JRespir Crit Care Med 2002;165:508-13.

Gümüş S, Deniz Ö, Örs F, Çiçi F, Tozkoparan E, Yücel O ve ark. Genç hastalarda soliter pulmoner nodüllerin etiyolojisi. Solunum 2007;9:99-104.

Erasmus JJ, McAdams HP, Connoly JE.Solitary pulmonary nodules: Part II.Evaluation of the indeterrminate nodule. Radiographics 2000;20:59-66.

Gould MK,Maclean CC,Kuschner WG. Accuracy of positron emissiontomography for diagnosis of pulmonary nodules and mass lesions. JAMA2001;285:914-924.

Detterbeck FC, Falen S, Rivera MP. Seeking a Home for a PET, Part 1Defining the Appropriate Place for Positron Emission Tomography Imaging in theDiagnosis of Pulmonary Nodules or Masses. Chest 2004; 125:2294-2299.

Lillington GA. Management of solitary pulmonary nodules. How to decide when resection is required. Postgrad Med. 1997 Mar;101(3):145-50. doi: 10.3810/pgm.1997.03.177. PMID: 9074555.

Mery CM,Pappas AN,Mentzer SJ, Sugarbaker DJ. Relationship between ahistory of antecedent cancer and the probability of malignancy for a solitarypulmonary nodule. Chest 2004;125:2175-81.

Downloads

Published

2026-03-07

How to Cite

Cengiz, Özgür, & Balta, C. (2026). Surgical Management and Pathological Outcomes of Pet-Avid Solitary Pulmonary Nodules: A Single-Center Retrospective Cohort: Research Article. Acta Medica Ruha, 4(1), 6–11. https://doi.org/10.5281/zenodo.18900021

Issue

Section

Research Articles